The Pharmaceutical Journal
Vol 279 No 7465 p175
18 August 2007

This article
Reprint   Photocopy

  Acrobat Reader

News summary

NXY-059 shown ineffective

Experimental neuroprotective agent NXY-059 (PJ, 18 February 2006, p197) has failed to show efficacy (New England Journal of Medicine 2007;357:562).

In a trial of 3,195 patients, given NXY-059 or placebo within six hours of acute ischaemic stroke, there was no difference in mortality, disability or scores of daily living between the two groups.